Susquehanna International Group’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Susquehanna International Group’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-27,566	Closed	-$1.32M	–	11493
2020 Q1	$1.32M	Buy	27,566 +22,473	+441%	+$1.05M	﹤0.01%	4743
2019 Q4	$239K	Sell	5,093 -23,602	-82%	-$1.04M	﹤0.01%	8445
2019 Q3	$679K	Sell	28,695 -12,468	-30%	-$369K	﹤0.01%	6600
2019 Q2	$1.24M	Buy	+41,163	New	+$943K	﹤0.01%	5180

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Susquehanna International Group's RARX Position: Q2 2020 in Review

Susquehanna International Group sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 27,566 shares — an estimated $1.32M sold.

Susquehanna International Group first reported a position in RARX in Q2 2019 and held it in 4 quarters. The position peaked at $1.32M in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Susquehanna International Group reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Susquehanna International Group sold 27,566 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $1.32M.
Susquehanna International Group first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q2 2019 and held it in 4 quarters.
Susquehanna International Group's Ra Pharmaceuticals, Inc. Common Stock position peaked at $1.32M in Q1 2020.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Susquehanna International Group's 13F filing for Q2 2020, filed 14 Aug 2020.